24 August 2026
Latham & Watkins Advises on Oversubscribed US$150 Million Private Placement in Connection With Werewolf Therapeutics and Ambros Therapeutics’ Reverse Merger Transaction
Advising firms
Deal team
3 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Matt Bush Lead | Latham & Watkins LLP | Partner | corporate | San Diego |
| Omeed Valipour | Latham & Watkins LLP | Associate | corporate | Not stated |
| Ariana Alemi | Latham & Watkins LLP | Associate | corporate | Not stated |
Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 150m (US$150 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Werewolf Therapeutics, Inc. (Other)
Ambros Therapeutics, Inc. (Other)